Dear Editor,
The number of cases of novel coronavirus disease (COVID-19) has risen dramatically across the world in recent weeks. The most frequently reported symptoms in a recent meta-analysis of 46,248 infected patients include fever (91%), cough (67%), fatigue (51%), and dyspnea (30%).1 However, a recent review has demonstrated that gastrointestinal symptoms including anorexia (40–50%), diarrhea (2–50%), vomiting (4–67%), nausea (1–29%), abdominal pain (2–6%) and gastrointestinal bleeding (4–14%) may also occur in patients with COVID-19.2 In some cases, gastrointestinal symptoms may be the only presenting findings.3 Studies have shown that the ACE2 receptor, the host cell receptor responsible for mediating infection by COVID-19, is highly expressed in absorptive enterocytes of the bowel, in addition to the lungs.4 The presence of COVID-19 in the gastrointestinal system is supported by fecal RT-PCR positivity in some patients.5
The rise in reporting of gastrointestinal symptoms related to COVID-19 has important potential implications for radiographers. Firstly, it's necessary to recognize that while uncommon, gastrointestinal symptoms may be the presenting finding of COVID-19 in some patients. This highlights the need for stringent cleanliness and strict adherence to regional public health recommendations in radiology departments, regardless of respiratory-related patient symptomatology. Secondly, radiographers should be prepared that the number of requests for COVID-19 related abdominal imaging may increase. For instance, exclusion of secondary causes for abdominal pain may be requested in patients with suspected or known COVID-19 disease. Abdominal organs with high concentrations of ACE2 expression may be theoretically vulnerable to COVID-19 related infections. These sites notably include the esophagus, ileum, kidneys, and bladder.6 In particular, the ileum contains approximately 30% ACE2-positive epithelial cells. At the present time, there are no known imaging reports of COVID-19 related inflammatory changes in these abdominal organs. Finally, imaging requests to evaluate the cause of gastrointestinal bleeding may increase as the number of suspected or confirmed COVID-19 cases continue to rise. This may be especially true if these patient demonstrates bright red blood per rectum, declining hemoglobin, and/or hemodynamic instability.
Financial support
None.
Conflict of interest statement
None to declare.
Acknowledgements
None.
Contributor Information
M.P. Wilson, Email: mitch.wilson@ualberta.ca.
P. Katlariwala, Email: prayashvk@gmail.com.
G. Low, Email: timgy@yahoo.com.
References
- 1.Yang J., Zheng Y., Gou X. Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection a systematic review and meta-analysis. Int J Infect Dis. 2020 doi: 10.1016/j.ijid.2020.03.017. Epub ahead of print. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Tian Y., Rong L., Nian W. Gastrointestinal features in COVID-19 and the possibility of fecal transmission. Aliment Pharmacol Ther. 2020 doi: 10.1111/apt.15731. Epub ahead of print. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.An P., Chen H., Jiang X. Clinical features of 2019 novel coronavirus pneumonia presented gastrointestinal symptoms but without fever onset. Lancet. 2020 Epub ahead of print. [Google Scholar]
- 4.Zhang H., Kang Z., Gong H. The digestive system is a potential route of 2019-nCov infection: a bioinformatics analysis based on single-cell transcriptomes. bioRxiv. 2020 [Epub ahead of print] [Google Scholar]
- 5.Hindson J. COVID-19: faecal-oral transmission? Nat Rev Gastroenterol Hepatol. 2020 doi: 10.1038/s41575-020-0295-7. Epub ahead of print. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Zou X., Chen K., Han P. Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. Front Times. 2020 doi: 10.1007/s11684-020-0754-0. [Epub ahead of print] [DOI] [PMC free article] [PubMed] [Google Scholar]